Sniper2L is a high-fidelity Cas9 variant with high activity

被引:17
|
作者
Kim, Young-hoon [1 ,2 ,3 ,4 ]
Kim, Nahye [2 ,5 ]
Okafor, Ikenna [6 ]
Choi, Sungchul [2 ]
Min, Seonwoo [7 ]
Lee, Joonsun [1 ]
Bae, Seung-Min [1 ]
Choi, Keunwoo [1 ]
Choi, Janice [8 ]
Harihar, Vinayak [8 ]
Kim, Youngho [1 ]
Kim, Jin-Soo [9 ,10 ]
Kleinstiver, Benjamin P. [11 ,12 ,13 ]
Lee, Jungjoon K. [1 ]
Ha, Taekjip [8 ,14 ,15 ,16 ]
Kim, Hyongbum Henry [2 ,4 ,5 ,17 ,18 ,19 ,20 ]
机构
[1] Toolgen, Seoul, South Korea
[2] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Grad Program Biomed Engn, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Grad Program Nanosci & Technol, Seoul, South Korea
[5] Yonsei Univ, Grad Sch Med Sci, Brain Korea Project 21, Coll Med, Seoul, South Korea
[6] Johns Hopkins Univ, Dept Biol, Baltimore, MD USA
[7] LG AI Res, Seoul, South Korea
[8] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA
[9] Natl Univ Singapore, Dept Biochem, Singapore, Singapore
[10] Natl Univ Singapore, NUS Synthet Biol Clin & Technol Innovat SynCTI, Singapore, Singapore
[11] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[12] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[13] Harvard Med Sch, Dept Pathol, Boston, MA USA
[14] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA
[15] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[16] Howard Hughes Med Inst, Baltimore, MD 21250 USA
[17] Inst for Basic Sci Korea, Ctr Nanomed, Seoul, South Korea
[18] Yonsei Univ, Yonsei Inst Basic Sci Inst, Seoul, South Korea
[19] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea
[20] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
TARGET CLEAVAGE; DNA; RNA; CRISPR; SPECIFICITY; NUCLEASES; COMPLEX;
D O I
10.1038/s41589-023-01279-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although several high-fidelity SpCas9 variants have been reported, it has been observed that this increased specificity is associated with reduced on-target activity, limiting the applications of the high-fidelity variants when efficient genome editing is required. Here, we developed an improved version of Sniper-Cas9, Sniper2L, which represents an exception to this trade-off trend as it showed higher specificity with retained high activity. We evaluated Sniper2L activities at a large number of target sequences and developed DeepSniper, a deep learning model that can predict the activity of Sniper2L. We also confirmed that Sniper2L can induce highly efficient and specific editing at a large number of target sequences when it is delivered as a ribonucleoprotein complex. Mechanically, the high specificity of Sniper2L originates from its superior ability to avoid unwinding a target DNA containing even a single mismatch. We envision that Sniper2L will be useful when efficient and specific genome editing is required.
引用
收藏
页码:972 / +
页数:31
相关论文
共 50 条
  • [31] Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing
    Wei, Jingjing
    Liu, Jingtong
    Wang, Ziwen
    Yang, Yuan
    Tian, Yuwen
    Wang, Shengzhou
    Gao, Bao-Qing
    Gao, Song
    Yang, Li
    Tang, Junnan
    Wang, Yongming
    PLOS BIOLOGY, 2024, 22 (06)
  • [32] Simultaneous knockout of multiple LHCF genes using single sgRNAs and engineering of a high-fidelity Cas9 for precise genome editing in marine algae
    Sharma, Amit K.
    Nymark, Marianne
    Flo, Snorre
    Sparstad, Torfinn
    Bones, Atle M.
    Winge, Per
    PLANT BIOTECHNOLOGY JOURNAL, 2021, 19 (08) : 1658 - 1669
  • [33] Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants
    Shor, Oded
    Rabinowitz, Roy
    Offen, Daniel
    Benninger, Felix
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 2013 - 2019
  • [34] Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity
    Seamon, Kyle J.
    Light, Yooli K.
    Saada, Edwin A.
    Schoeniger, Joseph S.
    Harmon, Brooke
    ANALYTICAL CHEMISTRY, 2018, 90 (11) : 6913 - 6921
  • [35] High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells
    Idoko-Akoh, Alewo
    Taylor, Lorna
    Sang, Helen M.
    McGrew, Michael J.
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Preclinical optimization of gene editing for adoptive T cell therapy with high fidelity CRISPR/Cas9 ribonucleoproteins
    Papademetriou, I. T.
    Cory, E.
    Sellman, M.
    Yoder, D.
    Barco, P.
    Brady, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A67 - A67
  • [37] High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells
    Alewo Idoko-Akoh
    Lorna Taylor
    Helen M. Sang
    Michael J. McGrew
    Scientific Reports, 8
  • [38] Restoring of wild-type activity level of high-fidelity SpyCas9 forms
    Karpov, D.
    Spasskaya, D.
    Davletshin, A.
    Garbuz, D.
    FEBS OPEN BIO, 2021, 11 : 283 - 284
  • [39] High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects
    Kleinstiver, Benjamin P.
    Pattanayak, Vikram
    Prew, Michelle S.
    Tsai, Shengdar Q.
    Nguyen, Nhu T.
    Joung, J. Keith
    MOLECULAR THERAPY, 2016, 24 : S288 - S288
  • [40] High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
    Ackermann, Amanda M.
    Zhang, Jia
    Heller, Aryel
    Briker, Anna
    Kaestner, Klaus H.
    MOLECULAR METABOLISM, 2017, 6 (03): : 236 - 244